Skip to main content
 

Human Embryo Research and Cloning Prohibitions

NIH funds may not be used for (1) the creation of a human embryo or embryos for research purposes; or (2) for research in which a human embryo or embryos are destroyed, discarded, or knowingly subjected to risk of injury or death greater than that allowed for research on fetuses in utero under 45 CFR 46.204(b) and subsection 498(b) of the PHS Act (42 U.S.C. 289g(b)). The term "human embryo or embryos" includes any organism not protected as a human subject under 45 CFR 46, as of the date of enactment of the governing appropriations act, that is derived by fertilization, parthenogenesis, cloning, or any other means from one or more human gametes or human diploid cells. Furthermore, per the NIH Director's Statement of April 28, 2015, NIH will not fund any use of gene-editing technologies in human embryos.

By Presidential memorandum of March 4, 1997, NIH is prohibited from using Federal funds for cloning of human beings.

Controlled Substances

Continuation of prohibition on use of funds for any activity that promotes the legalization of controlled substances, except this does not apply where there is medical evidence of therapeutic value or Federally-sponsored clinical trials are being conducted to determine such advantage. (Sec. 510)

  1. None of the funds made available in this Act may be used for any activity that promotes the legalization of any drug or other substance included in schedule I of the schedules of controlled substances established by section 202 of the Controlled Substances Act (21 U.S.C. 812).
  2. The limitation in subsection (a) shall not apply when there is significant medical evidence of a therapeutic advantage to the use of such drug or other substance or that federally sponsored clinical trials are being conducted to determine therapeutic advantage.

The page was last updated on Wednesday, May 22, 2019 - 4:16pm